Performance of MRK Merck & Company | 12.4% in 12m
Compare MRK with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Merck & Company with its related Sector/Index XLV
Performance Duell MRK vs XLV
| TimeFrame | MRK | XLV |
|---|---|---|
| 1 Day | -0.05% | 1.30% |
| 1 Week | 1.46% | 1.89% |
| 1 Month | 2.45% | -2.85% |
| 3 Months | 6.55% | 1.31% |
| 6 Months | 24.4% | 11.93% |
| 12 Months | 12.4% | 6.35% |
| YTD | 12.8% | 2.18% |
| Rel. Perf. 1m | 0.61 | |
| Rel. Perf. 3m | 1.35 | |
| Rel. Perf. 6m | 1.34 | |
| Rel. Perf. 12m | 0.63 |
Is Merck & Company a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Merck & Company is currently (April 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.76 and therefor a neutral outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRK as of April 2024 is 125.99. This means that MRK is currently overvalued and has a potential downside of -0.7%.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRK as of April 2024 is 125.99. This means that MRK is currently overvalued and has a potential downside of -0.7%.
Is MRK a buy, sell or hold?
- Strong Buy: 16
- Buy: 5
- Hold: 3
- Sell: 2
- Strong Sell: 0
Values above 0%: MRK is performing better - Values below 0%: MRK is underperforming
Compare MRK with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.04% | 5.44% | 3.32% | -11.89% |
| US NASDAQ 100 | QQQ | 2.86% | 7.22% | 4.47% | -23.01% |
| US Dow Jones Industrial 30 | DIA | -0.51% | 4.81% | 6.43% | -3.43% |
| German DAX 40 | DBXD | -0.71% | 2.81% | 2.02% | -1.30% |
| UK FTSE 100 | ISFU | -1.65% | 2.06% | 11.61% | 6.99% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.33% | 3.03% | 23.02% | 27.20% |
| Hongkong Hang Seng | HSI | -2.49% | 6.30% | 31.25% | 34.74% |
| Japan Nikkei 225 | EXX7 | 3.72% | 10.21% | 7.14% | -5.65% |
| India NIFTY 50 | INDA | -0.22% | -0.56% | 5.21% | -17.23% |
| Brasil Bovespa | EWZ | -2.13% | 5.47% | 16.21% | -5.61% |
MRK Merck & Company vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.51% | 3.71% | 3.00% | -29.06% |
| Consumer Discretionary | XLY | 1.82% | 8.02% | 10.38% | -5.58% |
| Consumer Staples | XLP | -1.62% | 2.82% | 10.51% | 11.54% |
| Energy | XLE | -0.36% | -1.58% | 14.27% | -2.83% |
| Financial | XLF | -2.43% | 3.15% | -5.21% | -13.89% |
| Health Care | XLV | -0.43% | 5.30% | 12.51% | 6.08% |
| Industrial | XLI | 0.37% | 4.16% | -1.91% | -11.65% |
| Materials | XLB | 2.05% | 5.83% | 4.62% | 1.54% |
| Real Estate | XLRE | 0.16% | 7.94% | 10.06% | 10.48% |
| Technology | XLK | 3.75% | 8.54% | 3.87% | -22.66% |
| Utilities | XLU | -4.23% | -1.43% | 7.10% | 14.36% |
| Aerospace & Defense | XAR | -0.01% | 4.95% | 5.47% | -5.09% |
| Biotech | XBI | 2.53% | 11.93% | -4.96% | 8.14% |
| Homebuilder | XHB | -0.57% | 8.46% | -21.88% | -37.71% |
| Retail | XRT | -1.46% | 7.88% | -1.28% | -5.90% |
Does Merck & Company outperform its market, is MRK a Sector Leader?
Yes, over the last 12 months Merck & Company (MRK) made 12.43%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.35%.
Over the last 3 months MRK made 6.55%, while XLV made 1.31%.
Yes, over the last 12 months Merck & Company (MRK) made 12.43%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.35%.
Over the last 3 months MRK made 6.55%, while XLV made 1.31%.
| Period | MRK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.45% | -2.85% | -2.99% |
| 3 Months | 6.55% | 1.31% | 4.61% |
| 12 Months | 12.43% | 6.35% | 24.32% |